Clinical trial
Study to Determine the Dose, the Safety and Effectiveness of a New Drug…
NCT00454220 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00454220 |
|---|---|
| Title | Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular Goiter |
| Official title | Study to Evaluate the Dose, Safety and Effectiveness of Modified-Release Recombinant Human Thyroid Stimulating Hormone (MRrhTSH) When Used in Conjunction With Radioiodine for the Treatment of Multinodular Goiter. |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multinodular Goiter |
| Intervention type | Drug, Other |
| Interventions | Placebo, MRrhTSH |
| Enrollment | 96 |
| Start date | Jul 1, 2007 |
| Primary completion | Jul 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Mar 30, 2007 |
| Last update posted | Jun 7, 2022 |
| Countries | Brazil, Canada, Denmark, France, Germany, Italy, Netherlands, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: